These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17427942)

  • 41. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
    Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
    Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy.
    Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
    Auton Neurosci; 2005 Apr; 119(1):56-60. PubMed ID: 15893708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease.
    Shalash AS; Hamid E; Elrassas H; Bahbah EI; Mansour AH; Mohamed H; Elbalkimy M
    PLoS One; 2021; 16(1):e0245918. PubMed ID: 33503062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
    Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
    Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?
    Nakamura T; Hirayama M; Hara T; Hama T; Watanabe H; Sobue G
    Mov Disord; 2011 Aug; 26(10):1869-74. PubMed ID: 21542023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased body mass index associated with autonomic dysfunction in Parkinson's disease.
    Mochizuki H; Taniguchi A; Nakazato Y; Ishii N; Ebihara Y; Sugiyama T; Shiomi K; Nakazato M
    Parkinsonism Relat Disord; 2016 Mar; 24():129-31. PubMed ID: 26774537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease.
    Kim JS; Shim YS; Song IU; Yoo JY; Kim HT; Kim YI; Lee KS
    Parkinsonism Relat Disord; 2009 Nov; 15(9):706-8. PubMed ID: 19251463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype.
    Solla P; Cadeddu C; Cannas A; Deidda M; Mura N; Mercuro G; Marrosu F
    J Neural Transm (Vienna); 2015 Oct; 122(10):1441-6. PubMed ID: 25797035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.
    Isaias IU; Benti R; Cilia R; Canesi M; Marotta G; Gerundini P; Pezzoli G; Antonini A
    Neuroreport; 2007 Sep; 18(14):1499-502. PubMed ID: 17712282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects.
    Morozumi T; Kusuoka H; Fukuchi K; Tani A; Uehara T; Matsuda S; Tsujimura E; Ito Y; Hori M; Kamada T; Nishimura T
    J Nucl Med; 1997 Jan; 38(1):49-52. PubMed ID: 8998149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder].
    Hakusui S; Yasuda T; Yanagi T; Takahashi A; Hasegawa Y; Inoue M
    Rinsho Shinkeigaku; 1994 Apr; 34(4):402-4. PubMed ID: 8026141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac innervation and clinical correlates in idiopathic Parkinson's disease.
    Akincioglu C; Unlu M; Tunc T
    Nucl Med Commun; 2003 Mar; 24(3):267-71. PubMed ID: 12612467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression.
    Baumann CR; Held U; Valko PO; Wienecke M; Waldvogel D
    Mov Disord; 2014 Feb; 29(2):207-13. PubMed ID: 24105646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autonomic dysfunction according to disease progression in Parkinson's disease.
    Kim JB; Kim BJ; Koh SB; Park KW
    Parkinsonism Relat Disord; 2014 Mar; 20(3):303-7. PubMed ID: 24382402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [123I-metaiodobenzylguanidine myocardial scintigraphy in the differential diagnosis of patients with parkinsonian syndromes -- case reports].
    Leńska-Mieciek M; Derecka-Charzyńska I; Fiszer U; Królicki L; Kułakowski P
    Neurol Neurochir Pol; 2005; 39(5):424-8. PubMed ID: 16273470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease.
    Nakamura T; Hirayama M; Yamashita F; Uchida K; Hama T; Watanabe H; Sobue G
    Mov Disord; 2010 Jul; 25(9):1183-9. PubMed ID: 20629159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating motor progression trajectory pursuant to temporal dynamic status of cardiac denervation in Parkinson's disease.
    Yoo SW; Ryu DW; Oh YS; Ha S; Lyoo CH; Kim Y; Yoo JY; Kim JS
    J Neurol; 2024 Apr; 271(4):2019-2030. PubMed ID: 38183421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease.
    Umehara T; Matsuno H; Toyoda C; Oka H
    J Neurol; 2015 Jul; 262(7):1762-8. PubMed ID: 25987207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral and Extracranial Neurodegeneration are Strongly Coupled in Parkinson's Disease.
    Spiegel J; Hellwig D; Jost WH; Farmakis G; Samnick S; Fassbender K; Kirsch CM; Dillmann U
    Open Neurol J; 2007; 1():1-4. PubMed ID: 19018276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.